Based on the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), breast cancer is categorized into several subtypes, including hormone receptor (HR)-positive, HER2-positive, and triple-negative breast cancer (TNBC) [3]. Here, ESR1 is linked to triple-negative breast carcinoma.